Categories: News

HHS Technology Group and Mathematica Delivering Analytics to Help Americans Self-Assess Personal Risk During Pandemic

FacebookFacebookTwitterTwitterEmailEmailLinkedInLinkedInWhatsAppWhatsAppMessengerMessengerFlipboardFlipboardGmailGmailTelegramTelegramShareShare

FORT LAUDERDALE, Fla., June 8, 2021 /PRNewswire/ — HHS Technology Group, LLC™ (HTG) and Mathematica announced their collaboration on a new health assessment platform that will account for individual health factors to provide a personalized risk score for helping individuals estimate their personal probability of contracting COVID-19 as a result of engaging in common activities, such as attending sporting events and dining in restaurants.

The comprehensive digital health tool for smart phones, tablets and personal computers will compute personal health risk beyond a simple red, yellow or green threat. This unique solution will enable individuals to perform a health self-assessment as a means of protecting themselves against COVID-19, as local economies around the country re-open.

The Health Risk Calculator will calculate a personal risk score for users, accounting for health markers based on individuals’ demographics, pre-existing conditions, vaccination status, and health behaviors to enable users to gauge the threat of potentially adverse situations. The risk score will be derived from users’ personal data, in addition to a risk methodology that will synthesize reported COVID-19 geographic case data and rapidly evolving scientific research to help users estimate their potential risk of infection or complications.  

The blockchain-based system, developed on Amazon GovCloud Infrastructure, will use the latest in geo-fencing technology to assess geographical risk and provide the most advanced approach to protecting individual privacy.

“Many Americans are resuming the once-common activities they gave up during the pandemic, but face confusion and uncertainty due to sometimes-conflicting health advice and guidelines from various local, regional and federal authorities,” said Brett Furst, President, HTG. “This tool will help empower individuals in assessing their own risk and guiding more informed decisions, as pandemic-related restrictions continue to relax.”  

“For many people, ready access to a health assessment tool like this alleviates privacy concerns about sharing sensitive health information,” said Bill Reeves, Director of Strategic Partnerships, Mathematica.

About HHS Technology Group, LLC 
HHS Technology Group is a software and solutions company serving the needs of commercial enterprises and government agencies. HHS Tech Group delivers modular software solutions, custom development, and integration services for modernization and operation of systems supporting a wide spectrum of business and government needs. For more information about HHS Technology Group, visit www.hhstechgroup.com. 

About Mathematica
Mathematica applies expertise at the intersection of data, methods, policy, and practice to improve well-being around the world. We collaborate closely with public- and private-sector partners to translate big questions into deep insights that improve programs, refine strategies, and enhance understanding. Learn about our work at Mathematica.org.

 

Media Contact: 
Brandon Glenn 
Amendola Communications
(773) 450-8815  
bglenn@acmarketingpr.com  

View original content to download multimedia:http://www.prnewswire.com/news-releases/hhs-technology-group-and-mathematica-delivering-analytics-to-help-americans-self-assess-personal-risk-during-pandemic-301307652.html

SOURCE HHS Technology Group

Staff

Recent Posts

Epic UGM 2025 Survival Guide: Insider Tips for Vendors, Storytellers, and Market Watchers

Black Book Research Marks Its 12th Year on the Ground in Verona with Independent, Vendor-Agnostic…

16 hours ago

rYojbaba Co., Ltd. Announces Closing of $5 Million Initial Public Offering of Japanese Common Shares

FUKUOKA, Japan, Aug. 15, 2025 (GLOBE NEWSWIRE) -- rYojbaba Co., Ltd. (Nasdaq: RYOJ) (“rYojbaba” or…

19 hours ago

Novo Nordisk A/S: Wegovy® approved in the US for the treatment of MASH

Bagsværd, Denmark, 15 August 2025 – Novo Nordisk today announced that the US Food and Drug…

19 hours ago

BioSig Technologies, Inc. & Streamex Announce Closing of $15 Million Public Offering

Offering Structured to Accelerate Streamex’s Operational Build-Out, Strategically Allocated with No WarrantsLos Angeles, CA, Aug.…

19 hours ago

Jabez Biosciences, Inc. Opens Second Clinical Site in Phase 1 Oncology Clinical Study of JBZ-001

CRANBERRY TOWNSHIP, Pa., Aug. 15, 2025 (GLOBE NEWSWIRE) -- Jabez Biosciences, Inc., a clinical-stage biopharmaceutical…

19 hours ago